Englander Institute for Precision Medicine
EIPM

A powerful new test that can reveal untapped therapies for patients with advanced cancers by scanning thousands of their genes will soon be available for patients at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center. The test, EXaCT-1, identifies alterations within tumors — some of which drive cancerous growth — on a magnitude up to hundreds of times greater than similar...

WCMC

A significant investment in Weill Cornell’s leading precision medicine program by Overseer Israel Englander and his wife Caryl will expand the scope of the institution’s approach to understanding and treating disease through therapies customized to patients’ unique genetic profiles.

The gift names the ...

US News

The use of genetic data could fundamentally change how we treat disease.

Precision medicine can offer more tailored treatment options for patients.

This year may just be the year of precision medicine – a term that’s buzzing on health blogs and in research journals. Precision techniques, proponents say, could change the face of medicine forever.

Simply put, precision medicine is the practice of using genetic information about a person’s disease to treat it. “It’s an...